35.21
前日終値:
$35.39
開ける:
$35.2
24時間の取引高:
953.76K
Relative Volume:
1.11
時価総額:
$1.31B
収益:
$272.30M
当期純損益:
$-5.14M
株価収益率:
-215.35
EPS:
-0.1635
ネットキャッシュフロー:
$42.76M
1週間 パフォーマンス:
+6.70%
1か月 パフォーマンス:
-12.50%
6か月 パフォーマンス:
-15.73%
1年 パフォーマンス:
+29.45%
Harrow Inc Stock (HROW) Company Profile
Compare HROW vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
HROW
Harrow Inc
|
35.21 | 1.32B | 272.30M | -5.14M | 42.76M | -0.1635 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.96 | 51.03B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.32 | 40.20B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.06 | 40.78B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
77.69 | 32.81B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
556.82 | 23.86B | 3.17B | 1.29B | 1.01B | 27.09 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 開始されました | BTIG Research | Buy |
| 2025-06-10 | 開始されました | William Blair | Outperform |
| 2025-02-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-04 | 繰り返されました | B. Riley Securities | Buy |
| 2024-04-11 | 開始されました | Craig Hallum | Buy |
| 2022-09-08 | 再開されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-09-24 | 開始されました | Aegis Capital | Buy |
| 2021-07-02 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Harrow Inc (HROW) 最新ニュース
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference - GlobeNewswire
Harrow (HROW) Is Up 6.8% After Reaffirming 2026 Revenue Outlook Despite Wider Q1 LossesWhat's Changed - simplywall.st
HROW News | HARROW INC (NASDAQ:HROW) - ChartMill
Harrow Inc (HROW) Shares Surge 6.8% -- What GF Score of 82 Tells Investors - GuruFocus
Why B.Riley Reduced Harrow, Inc. (HROW) Price Target Despite Long-Term Optimism - Insider Monkey
Harrow: Demand Keeps It Interesting, Valuation Keeps It A Hold - Seeking Alpha
Harrow, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HROW) 2026-05-19 - Seeking Alpha
Harrow director Lauren Silvernail buys $31,000 in company stock By Investing.com - Investing.com Nigeria
Harrow director Adrienne Graves buys $31,070 in company stock By Investing.com - Investing.com Nigeria
Harrow director Lauren Silvernail buys $31,000 in company stock - Investing.com India
Insider Buying: Adrienne Graves Acquires Shares of Harrow Inc (H - GuruFocus
5 Best Small Cap Pharma Stocks to Buy Right Now - Insider Monkey
Harrow director Adrienne Graves buys $31,070 in company stock - Investing.com
Harrow (HROW) director Adrienne Graves buys 1,000 shares at $31.07 - Stock Titan
Harrow (HROW) director purchases 1,000 common shares at $31.00 price - Stock Titan
Harrow projects $71M-$81M Q2 revenue while reaffirming $350M-$365M 2026 outlook - MSN
[Form 4] HARROW, INC. Insider Trading Activity - Stock Titan
Mark Baum Buys Handful Of Shares In Harrow - Yahoo Finance
Harrow’s TRIESENCE Phase 3 Milestone Adds New Dimension To Growth Story - Sahm
Harrow Stock (HROW) Opinions on Q1 Earnings and Insider Buying - Quiver Quantitative
Harrow (HROW) Executives Make Notable Stock Purchases - GuruFocus
Why Harrow (HROW) Narrative Is Shifting As Analysts Recut Targets Yet Stay Positive - Yahoo Finance
Insider Buying: Mark Baum Acquires Additional Shares of Harrow I - GuruFocus
Harrow Insider Bought Shares Worth $302,000, According to a Recent SEC Filing - Moomoo
Harrow, Inc. CEO Mark L. Baum buys $302,000 in common stock - Investing.com India
Harrow president and CFO Andrew Boll buys $104,650 in stock By Investing.com - Investing.com Australia
Harrow president and CFO Andrew Boll buys $104,650 in stock - Investing.com India
Harrow, Inc. CEO Mark L. Baum buys $302,000 in common stock By Investing.com - Investing.com South Africa
Harrow (HROW) CEO Mark Baum acquires 10,000 shares in open-market buy - Stock Titan
Harrow (NASDAQ: HROW) CFO adds 3,500 shares in open-market buy - Stock Titan
Harrow Inc (HROW) Shares Surge 3.5% -- What GF Score of 82 Tells Investors - GuruFocus
B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $60 - Moomoo
B. Riley Adjusts Price Target on Harrow to $60 From $65, Maintains Buy Rating - Moomoo
The Harrow, Inc. (NASDAQ:HROW) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
Why Harrow (HROW) Is Down 25.9% After Q1 Miss And Reaffirmed 2026 Guidance – And What's Next - simplywall.st
HROW Maintained by Cantor Fitzgerald -- Price Target Lowered to $88 - GuruFocus
Transcript: Harrow Q1 2026 Earnings Conference Call - Sahm
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $88 - Moomoo
HROW Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Harrow for Potential Securities Law Violations - marketscreener.com
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Harrow Health, Inc. (NASDAQ:HROW) Q1 2026 Earnings Call Transcript - Insider Monkey
Harrow Inc (HROW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):